Farms.com Home   News

Ag Robots May Be A $74 Billion Global Business

These are exciting days for agri technology companies as they bring new concepts to the market to help farmers increase productivity.

The market for agricultural robots is developing at a rapid pace, with a large number of established and startup agricultural technology companies developing, piloting, and launching an innovative range of robotic systems to tackle a wide variety of tasks. Key application areas for agricultural robots include driverless tractors, unmanned aerial vehicles (UAVs), material management, field crops and forest management, soil management, dairy management, and animal management, with a diverse set of subcategories emerging within each of those areas.

According to a new report from Tractica, developed in collaboration with The Robot Report, shipments of agricultural robots will increase significantly in the years ahead, rising from 32,000 units in 2016 to 594,000 units annually in 2024, by which time the market is expected to reach $74.1 billion in annual revenue.

Driverless tractors, agricultural drones, material management robots, and soil management robots will drive the highest volumes in unit shipments.

"The rising demand for agricultural robots is being driven by a number of factors including global population growth, increasing strain on the food supply, declining availability of farm workers, the challenges, costs, and complexities of farm labor, changing farmlands, climate change, the growth of indoor farming, and the broader automation of the agriculture industry," says Tractica research analyst Manoj Sahi.
 


Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.